Ping Chen

11.6k total citations · 1 hit paper
358 papers, 7.8k citations indexed

About

Ping Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ping Chen has authored 358 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 95 papers in Oncology and 54 papers in Cancer Research. Recurrent topics in Ping Chen's work include MicroRNA in disease regulation (25 papers), RNA Interference and Gene Delivery (24 papers) and Cancer-related molecular mechanisms research (22 papers). Ping Chen is often cited by papers focused on MicroRNA in disease regulation (25 papers), RNA Interference and Gene Delivery (24 papers) and Cancer-related molecular mechanisms research (22 papers). Ping Chen collaborates with scholars based in China, United States and Hong Kong. Ping Chen's co-authors include Benjamin K. Chen, Wolfgang Hübner, Matthew A. Spinelli, Xia Zhao, Jianjun Chen, Carol A. Nacy, Leo Einck, Liang Ma, Marina Protopopova and B. V. Nikonenko and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Ping Chen

345 papers receiving 7.7k citations

Hit Papers

Global Burden, Risk Factors, and Trends of Esophageal Can... 2021 2026 2022 2024 2021 40 80 120

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping Chen China 46 4.0k 1.5k 1.2k 1.1k 920 358 7.8k
Paola Matarrese Italy 50 3.7k 0.9× 751 0.5× 787 0.6× 1.7k 1.6× 1.1k 1.1× 175 7.5k
Xiaohong Wang China 50 5.2k 1.3× 2.9k 2.0× 1.4k 1.1× 1.3k 1.2× 799 0.9× 273 9.1k
Yan Chen China 45 5.1k 1.3× 2.0k 1.4× 1.3k 1.0× 1.6k 1.5× 1.2k 1.3× 379 8.9k
Paola Secchiero Italy 54 4.3k 1.1× 1.3k 0.9× 2.7k 2.2× 2.4k 2.2× 1.8k 2.0× 276 9.5k
Jun O. Liu United States 64 8.9k 2.2× 1.7k 1.1× 2.7k 2.3× 1.5k 1.4× 1.4k 1.6× 210 14.2k
Lu Gao China 41 2.1k 0.5× 787 0.5× 900 0.7× 1.2k 1.1× 1.5k 1.7× 254 5.9k
Shrikant Anant United States 56 5.3k 1.3× 1.5k 1.0× 2.2k 1.8× 1.5k 1.4× 742 0.8× 212 9.3k
Jing Ma China 38 4.8k 1.2× 2.1k 1.4× 1.6k 1.3× 1.2k 1.1× 755 0.8× 178 10.2k
Yu Wang China 37 2.4k 0.6× 1.2k 0.8× 770 0.6× 1.0k 1.0× 1.6k 1.7× 247 5.9k
Diana C. Haines United States 43 2.7k 0.7× 761 0.5× 949 0.8× 1.1k 1.0× 344 0.4× 63 5.3k

Countries citing papers authored by Ping Chen

Since Specialization
Citations

This map shows the geographic impact of Ping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping Chen more than expected).

Fields of papers citing papers by Ping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping Chen. The network helps show where Ping Chen may publish in the future.

Co-authorship network of co-authors of Ping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ping Chen. A scholar is included among the top collaborators of Ping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping Chen. Ping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hu, Yue, Xi He, Ping Chen, et al.. (2025). Lung-targeted delivery of PTEN mRNA combined with anti-PD-1-mediated immunotherapy for In Situ lung cancer treatment. Acta Biomaterialia. 194. 442–454. 4 indexed citations
3.
Chen, Ping, et al.. (2024). MiRNA29a-3p negatively regulates ISL1–Integrin β1 axis to suppress gastric cancer progression. Experimental Cell Research. 443(1). 114288–114288.
4.
Chen, Ping, et al.. (2024). Development of a Stringent Ex Vivo-Burned Porcine Skin Wound Model to Screen Topical Antimicrobial Agents. Antibiotics. 13(12). 1159–1159. 3 indexed citations
6.
Tan, Liming, et al.. (2023). Circular RNA XRCC5 aggravates glioma progression by activating CLC3/SGK1 axis via recruiting IGF2BP2. Neurochemistry International. 166. 105534–105534. 6 indexed citations
7.
Chen, Ping, et al.. (2023). Ginkgo biloba Golden Leaf Extract (GGLE) Inhibits Melanoma Cell Invasion and Angiogenesis Through Inhibition of Angiogenin. Integrative Cancer Therapies. 22. 1553449649–1553449649. 6 indexed citations
8.
Chen, Ping, et al.. (2022). Cerium Nitrate Stiffens In Vitro Skin Models and Reduces Pseudomonas aeruginosa Pathogenicity and Penetration Through Skin Models. Advances in Wound Care. 12(10). 546–559. 3 indexed citations
9.
Huang, Junjie, Anastasios Koulaouzidis, Wojciech Marlicz, et al.. (2021). Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries. Cancers. 13(1). 141–141. 127 indexed citations breakdown →
10.
Wang, Xi, Yiqun Jia, Liling Wen, et al.. (2021). Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome. Cancer Research. 81(10). 2745–2759. 145 indexed citations
11.
Chen, Ping, et al.. (2020). Effect of melatonin for the management of endometriosis. Medicine. 99(22). e20353–e20353. 2 indexed citations
12.
Zhao, Yumei, Peng Wu, Lantu Gou, et al.. (2020). <p>HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma</p>. International Journal of Nanomedicine. Volume 15. 6409–6420. 13 indexed citations
13.
Li, Jianping, et al.. (2020). Advanced primary squamous cell carcinoma of gallbladder and potential predictive biomarkers for prognosis. Journal of International Medical Research. 48(8). 1220746110–1220746110. 3 indexed citations
14.
Zhang, Ying, Shunzi Jin, Ping Chen, et al.. (2020). Paclitaxel-loaded dextran nanoparticles decorated with RVG29 peptide for targeted chemotherapy of glioma: anin vivostudy. New Journal of Chemistry. 44(15). 5692–5701. 18 indexed citations
15.
Yao, Ninghua, et al.. (2019). TRIM27 promotes the development of esophagus cancer via regulating PTEN/AKT signaling pathway. Cancer Cell International. 19(1). 283–283. 43 indexed citations
16.
Liu, Shousheng, Yuanzhong Yang, Chang Jiang, et al.. (2018). Comparison of immunological characteristics between paired mismatch repair-proficient and -deficient colorectal cancer patients. Journal of Translational Medicine. 16(1). 195–195. 16 indexed citations
17.
Wang, Bing, Ping Chen, Ji Zhang, et al.. (2017). Self-assembled core–shell-corona multifunctional non-viral vector with AIE property for efficient hepatocyte-targeting gene delivery. Polymer Chemistry. 8(48). 7486–7498. 26 indexed citations
18.
Chen, Ping, Tao Hu, Yupei Liang, et al.. (2016). Neddylation Inhibition Activates the Extrinsic Apoptosis Pathway through ATF4–CHOP–DR5 Axis in Human Esophageal Cancer Cells. Clinical Cancer Research. 22(16). 4145–4157. 99 indexed citations
19.
Fu, Jinxiang, et al.. (2009). BASIC RESEARCH SDF1/CXCR4 signalling promotes mobility of myeloma cells by activation and redistribution of cell surface adhesion molecules. Archives of Medical Science. 5(2). 141–148. 1 indexed citations
20.
Wang, Yongsheng, Dan Li, Shi H, et al.. (2009). Intratumoral Expression of Mature Human Neutrophil Peptide-1 Mediates Antitumor Immunity in Mice. Clinical Cancer Research. 15(22). 6901–6911. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026